These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 324058)

  • 1. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
    Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K
    Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
    Wulff K; Flachs H; Würtz-Jørgensen A; Gram L
    Ugeskr Laeger; 1977 May; 139(18):1059-64. PubMed ID: 324057
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M; Naestoft J; Lund M
    Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
    Tomlinson EB
    Proc Aust Assoc Neurol; 1974; 11():203-8. PubMed ID: 4620029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
    Trompetter-van Woerden ML; van der Zwan A
    Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: A controlled trial of sodium valproate in severe epilepsy.
    Richens A
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):428. PubMed ID: 51730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
    de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences].
    Lüdemann G; Cammann R-J ; Knaape H-H
    Psychiatr Neurol Med Psychol (Leipz); 1975 Feb; 27(2):101-7. PubMed ID: 812129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of choreic syndromes with sodium dipropylacetate].
    Piccinin G; Morocutti C; Urcioli R; Bernardi G
    Riv Neurol; 1977; 47(2):107-16. PubMed ID: 141095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of atypical absences with a combination of succinimide and dipropylacetate (author's transl)].
    Schneble H
    Dtsch Med Wochenschr; 1975 Jul; 100(30):1564-7. PubMed ID: 808402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 16. Sodium valproate (Epilim) in the treatment of refractory epilepsy.
    Lines DR
    N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Di-N-propylacetic acid in the epileptic syndrome].
    Broglia S; Colombo RS; Barberis F
    Clin Ter; 1972 Oct; 63(2):165-74. PubMed ID: 4566414
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems in serum-level determination during valproic acid therapy].
    Schäfer H; Reith H; Jacobs R; Gabriel KH
    Arzneimittelforschung; 1977; 27(6):1215-21. PubMed ID: 332187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the therapeutic action and side-effects of a new preparation of dipropylacetic acid].
    Gallassi R
    Clin Ter; 1977 Nov; 83(3):313-7. PubMed ID: 342177
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of di-no-propylacetate and clonazepam in epileptic patients.
    Baruzzi A; Bordo B; Bossi L; Castelli D; Gerna M; Tognoni G; Zagnoni P
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):403-8. PubMed ID: 334679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.